1. Health-related quality of life results from the IFM 2009 trial: treatment with lenalidomide, bortezomib, and dexamethasone in transplant-eligible patients with newly diagnosed multiple myeloma. Issue 6 (11th May 2020) Authors: Roussel, Murielle; Hebraud, Benjamin; Hulin, Cyrille; Perrot, Aurore; Caillot, Denis; Stoppa, Anne-Marie; Macro, Margaret; Escoffre, Martine; Arnulf, Bertrand; Belhadj, Karim; Karlin, Lionel; Garderet, Laurent; Facon, Thierry; Guo, Shien; Weng, Josh; Dhanasiri, Sujith; Leleu, Xavier; Moreau, Phil... Journal: Leukemia & lymphoma Issue: Volume 61:Issue 6(2020) Page Start: 1323 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. P3‐296: SIMULATED COGNITIVE TRAJECTORIES IN PATIENTS WITH/WITHOUT HISTORY OF STROKE WHO ARE AT RISK OF DEVELOPING ALZHEIMER'S DISEASE USING AD ACE. (1st July 2019) Authors: Tafazzoli, Ali; Weng, Josh; Kansal, Anuraag R. Journal: Alzheimer's & dementia Issue: Volume 15:Supplement 7S(2019)Part 20 Page Start: P1050 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗